Jump to content

Drilldown: Medicines

Choose a table:


Medicines > generic : 2-FDCK or 25I-NBOH or Epinephrine (adrenaline)

Use the filters below to narrow your results.

generic: (Click arrow to add another value)
brand:
None (2) · EpiPen, EpiPen Jr, Auvi-Q, Adrenaclick, Symjepi; many generic (1)
classes:
Classic Psychedelic (1) · Dissociative (1) · Phenethylamine (1) · Research material (2) · [[:Category:Catecholamines|Catecholamine]] (1) · [[:Category:Inotropes|Inotrope]] (1) · [[:Category:Sympathomimetics|Sympathomimetic]] (1) · [[:Category:Vasopressors|Vasopressor]] (1)
mechanism:
NMDA antagonist; fluorinated ketamine analogue (1) · Potent 5-HT2A agonist (1) · '"`UNIQ--vote-00000E4A-QINU`"' The narrow safe-bolus window for IV use (sharp risk of arrhythmia, hypertensive emergency, intracerebral hemorrhage) is why anaphylaxis dosing is '''IM, not IV''', outside critical care'"`UNIQ--ref-00000E4B-QINU`"'. (1)
uses:
None (2) · '"`UNIQ--vote-00000E4C-QINU`"', '"`UNIQ--vote-00000E4D-QINU`"', '"`UNIQ--vote-00000E4E-QINU`"', '"`UNIQ--vote-00000E4F-QINU`"', '"`UNIQ--vote-00000E50-QINU`"', '"`UNIQ--vote-00000E51-QINU`"' (1)
starting dose:
None (2) · Anaphylaxis IM 0.3-0.5 mg (adult) into lateral thigh, repeat q5-15 minutes prn; pediatric 0.01 mg/kg IM (max 0.3 mg, max 0.5 mg in adolescents); cardiac arrest 1 mg IV/IO q3-5 minutes; severe asthma neb 0.1 mg/kg up to 5 mg; never IV bolus for anaphylaxis outside critical care (1)
preparations:
None (2) · Auto-injectors 0.15 mg (Jr/pediatric), 0.3 mg (adult); 1 mg/mL (1:1,000) ampules for IM/SC use; 0.1 mg/mL (1:10,000) for IV use; 2.25% racemic nebulizer (1)
fda max:
None (2) · Indication-specific; ACLS no fixed cumulative ceiling (1)
routes:
None (2) · endotracheal (legacy ACLS (1) · IM (1) · intracardiac (historical only) (1) · IV (1) · nebulized (1) · not preferred) (1) · SC (less common) (1)
onset:
None (2) · IM: 5-10 minutes; IV: seconds; nebulized: 5-10 minutes (1)
duration:
None (2) · 5-15 minutes (1)
halflife:
None (2) · ~2 minutes'"`UNIQ--ref-00000E52-QINU`"' (1)
bioavailability:
None (2) · IM/SC ~100%; oral negligible (extensive first-pass and gut metabolism — hence the no-oral route)'"`UNIQ--ref-00000E53-QINU`"' (1)
pregnancy:
None (2) · Used in life-threatening obstetric anaphylaxis without hesitation; benefits clearly outweigh.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1)
legal:
None (2) · [[USLegal:Prescription only|Rx-only]] in US (1)

Showing below up to 3 results in range #1 to #3.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

2


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"